Dear John,

The March issue of Health Affairs features articles on a range of topics, including prescription drug policy, use, and patent challenges; physician turnover after private equity acquisition of physician practices; children’s health coverage loss during Medicaid unwinding; and more.

P H A R M A C E U T I C A L S   &   M E D I C A L 

M A R I J U A N A

Demographic Variation In US Outpatient Hydroxychloroquine And Ivermectin Use During The COVID-19 Pandemic

Michelle S. Rockwell et al.

Estimated Savings From Extending Prescription Drug Inflationary Rebates To All Commercial Plans

Marissa B. Reitsma et al.

First-In-Class Drugs Experienced Different Regulatory Treatment In The US And Europe

Jihye Han and Aaron S. Kesselheim

Changes In Biologic Drug Revenues After Administrative Patent Challenges

Adam J. N. Raymakers et al.

Arkansas Medical Marijuana Certifications: Higher-Volume Physicians Associated With Less Evidence Of Care Coordination

Joseph W. Thompson et al.

P R I V A T E   E Q U I T Y

Physician Turnover Increased In Private Equity–Acquired Physician Practices

Yashaswini Singh et al.

C H I L D   H E A L T H

Continuous Eligibility Policies And CHIP Structure Affected Children’s Coverage Loss During Medicaid Unwinding

Erica Eliason et al.

LIVE! with Yashaswini Singh

Next week, join us for a live taping of A Health Podyssey on March 12 with Yashaswini Singh about her paper in the March 2025 edition of Health Affairs.

Host Rob Lott and Singh will take questions from the audience as well.
 

This event is free and open to all.

Rewarding Medicare Advantage D-SNPs That Provide The Best Value

Ryan Stringer et al.

part of our Medicare and Medicaid Integration series

Reporting Requirements Matter (A Lot): Evidence From Arkansas's Medicaid Work Requirements

Morgan A. Henderson et al.